<DOC>
	<DOC>NCT00765427</DOC>
	<brief_summary>Healthy volunteer subjects will receive retinoid QLT091001 once-daily for 7 days for safety observation.</brief_summary>
	<brief_title>Safety and Tolerability of Retinoid QLT091001 in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Retinol acetate</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<criteria>Healthy subjects with ECG within normal limits and normal blood pressure and resting heart rate Subjects with any clinically important abnormal physical finding at screening. Subjects who are actively participating in an experimental therapy study or who have received experimental therapy within 60 days of baseline. Female subjects who are either pregnant or lactating.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>